Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3761105 | 0.93 | ZDHHC7 (0.43) | ZDHHC7GPR84FFAR1MAPTLCK | |
| SCHEMBL3179799 | 0.85 | ZDHHC7 (0.46) | ZDHHC7GPR84FFAR1MAPTLCK | |
| SCHEMBL8193028 | 0.83 | ZDHHC7 (0.58) | ZDHHC7GPR84FFAR1MAPTLCK | |
| SCHEMBL2117996 | 0.83 | ZDHHC7 (0.44) | ZDHHC7GPR84FFAR1MAPTLCK | |
| SCHEMBL5355140 | 0.83 | NAAA (0.50) | ZDHHC7MAPTFAAH | |
| SCHEMBL31499205 | 0.81 | ZDHHC7 (0.43) | ZDHHC7GPR84FFAR1MAPTLCK | |
| SCHEMBL28650931 | 0.81 | GPR84 (0.47) | ZDHHC7GPR84FFAR1MAPTFFAR4 | |
| SCHEMBL33770 | 0.79 | DGKA (0.50) | MAPTFFAR4 | |
| Benzoic Acid SCHEMBL5716633 | 0.79 | PRSS1 (0.43) | — | |
| SCHEMBL10537975 | 0.78 | ZDHHC7 (0.50) | ZDHHC7GPR84FFAR1MAPTLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240058235-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE CLAY, AT LEAST ONE CRYSTALLIZABLE FATTY COMPOUND AND AT LEAST ONE LIPOSOLUBLE UV FILTER | L'OREAL (FR) | 2024-02-22 | — | — | US | disclosed |
| EP-4267082-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE CLAY, AT LEAST ONE CRYSTALLIZABLE FATTY COMPOUND AND AT LEAST ONE LIPOSOLUBLE UV FILTER | L'OREAL (FR) | 2023-11-01 | — | — | EP | disclosed |
| EP-4153119-A1 | BARK-FREE, STABLE DOUBLE EMULSION | Capsum (FR) | 2023-03-29 | — | — | EP | disclosed |
| WO-2022136519-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE CLAY, AT LEAST ONE CRYSTALLIZABLE FATTY COMPOUND AND AT LEAST ONE LIPOSOLUBLE UV FILTER | L'OREAL (FR) | 2022-06-30 | — | — | WO | disclosed |
| WO-2021122639-A1 | TWO-PHASE COMPOSITION COMPRISING AN AQUEOUS PHASE COMPRISING ONE OR MORE POLYOLS AT A CONTENT RANGING FROM 5% TO 30% BY WEIGHT AND AN OILY PHASE COMPRISING NON-SILICONE OILS | L'OREAL (FR) | 2021-06-24 | — | — | WO | disclosed |
| WO-2017143036-A1 | MODULATORS OF MS4A ACTIVITY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-08-24 | — | — | WO | disclosed |
| EP-3082718-A1 | COSMETIC USE OF AN ESSENTIAL OIL OF LASERPITIUM SILER L. FOR KERATIN MATERIALS | L'OREAL (FR) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015092673-A1 | COSMETIC USE OF AN ESSENTIAL OIL OF LASERPITIUM SILER L. FOR KERATIN MATERIALS | L'OREAL (FR) | 2015-06-25 | — | — | WO | disclosed |
| EP-2861203-A2 | METHOD FOR TREATING OILY SKIN | L'Oréal (FR) | 2015-04-22 | — | — | EP | disclosed |
| WO-2013186716-A2 | METHOD FOR TREATING OILY SKIN | L'OREAL (FR) | 2013-12-19 | — | — | WO | disclosed |
| EP-2167029-B1 | LIP GLOSS | COTY S A S (FR) | 2013-09-18 | — | — | EP | disclosed |
| WO-2013041536-A1 | DEVICE FOR PACKAGING AND APPLYING A SOLID COSMETIC PRODUCT | L'OREAL (FR) | 2013-03-28 | — | — | WO | disclosed |
| US-8236289-B2 | Lip gloss | COTY S.A.S. (FR) | 2012-08-07 | — | — | US | disclosed |
| EP-2211825-A1 | ENCAPSULATED LOW VISCOSITY HYDROPHOBIC LIQUID ACTIVES | Dow Global Technologies Inc. (US) | 2010-08-04 | — | — | EP | disclosed |
| EP-2167029-A2 | LIP GLOSS | Coty S.A.S. (FR) | 2010-03-31 | — | — | EP | disclosed |
| WO-2009064739-A1 | ENCAPSULATED LOW VISCOSITY HYDROPHOBIC LIQUID ACTIVES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-05-22 | — | — | WO | disclosed |
| WO-2009035484-A1 | LIP GLOSS | NGUYEN LETHU T (US) | 2009-03-19 | — | — | WO | disclosed |
| US-20090060857-A1 | LIP GLOSS | COTY S.A.S. (FR) | 2009-03-05 | — | — | US | disclosed |
| US-20090047229-A1 | LIP GLOSS | COTY S.A.S (FR) | 2009-02-19 | — | — | US | disclosed |
| WO-2008156723-A2 | LIP GLOSS | COTY S.A.S (FR) | 2008-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240058235-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE CLAY, AT LEAST ONE CRYSTALLIZABLE FATTY COMPOUND AND AT LEAST ONE LIPOSOLUBLE UV FILTER | FABP4, CUTA, PLIN3 | ZDHHC7 4604/4885GPR84 3998/4885FFAR1 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.